Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2025 ARTÍCULOS , VIENDO DEL 1111 AL 1125

Patient-Related Barriers to Digital Technology Adoption in Alzheimer Disease: Systematic Review

Panzavolta A, Arighi A, Guido E, Lavorgna L, Di Lorenzo F, Dodich A, Cerami C.

JMIR Aging. 2025 Apr 10;8:e64324. doi: 10.2196/64324.

Safety and immunogenicity of two Tau-targeting active immunotherapies, ACI-35.030 and JACI-35.054, in participants with early Alzheimer's disease: a phase 1b/2a, multicentre, double-blind, randomised, placebo-controlled study

Sol O, Mermoud J, Hallikainen M, Kurl S, Rinne J, Dautzenberg P, Vijverberg EGB, Mummery C, Börjesson-Hanson A, Jonsson M, Ritchie C, Pennington C, Vukicevic M, Gollwitzer E, Fiorini E, Hickman DT, Hliva V, Gray J, Gerasymchuk V, Wagg J, Fournier N, Lê B, Kezic I, Steukers L, Triana-Baltzer G, Theunis C, Streffer J, Kosco-Vilbois M, Pfeifer A, Scheltens P.

EBioMedicine. 2025 Oct;120:105940. doi: 10.1016/j.ebiom.2025.105940. Epub 2025 Sep 18.

Strain specific effects of probiotic supplementation on serum amino acid profiles in Alzheimer's disease: a randomized, double blind, placebo controlled trial

Jouni N, Akhgarjand C, Vahabi Z, Shab-Bidar S, Khalifeh H, Djafarian K.

Sci Rep. 2025 Aug 15;15(1):29924. doi: 10.1038/s41598-025-15355-4.

Rapid health technology assessment of galantamine for the treatment of Alzheimer's disease: A review

Xing B, Yang J, Hua H, Jiang R.

Medicine (Baltimore). 2025 Jun 6;104(23):e42744. doi: 10.1097/MD.0000000000042744.

Physical activity changes during midlife link to brain integrity and amyloid burden

Akinci M, Aguilar-Domínguez P, Palpatzis E, Shekari M, García-Prat M, Deulofeu C, Fauria K, García-Aymerich J, Gispert JD, Suárez-Calvet M, Grau-Rivera O, Sánchez-Benavides G, Arenaza-Urquijo EM; ALFA study.

Alzheimers Dement. 2025 May;21(5):e70007. doi: 10.1002/alz.70007.

Gray matter and white matter functional connectivity changes induced by rTMS concurrent with cognitive training in Alzheimer's disease

Fang J, Shi Y, Ba L, Zhang M, Li M, Zheng N, Qin Y, Zhu W.

Brain Res Bull. 2025 Aug;228:111418. doi: 10.1016/j.brainresbull.2025.111418. Epub 2025 Jun 3.

Direct hybridization and bioinformatics analysis of circulating microRNAs in patients with Alzheimer's disease under intravenous trehalose treatment

Radbakhsh S, Abrego-Guandique DM, Bacchetti T, Aghaee-Bakhtiari SH, Mahmoudi A, Manteghi AA, Bazyari MJ, Cione E, Ferretti G, Sahebkar A.

Brain Res. 2025 Jun 15;1857:149607. doi: 10.1016/j.brainres.2025.149607. Epub 2025 Apr 3.

A review of the TGF-β1 pathway in Alzheimer's disease and depression: Possible restoration potential of antidepressants

Eleni I, Theofanis V, Zisis B, Eleni S.

Neuroscience. 2025 Oct 15;585:429-440. doi: 10.1016/j.neuroscience.2025.09.010. Epub 2025 Sep 12.

Correlation between changes in apathy and cognition in Alzheimer's disease associated apathy: Analysis of the Apathy in Dementia Methylphenidate Trial 2 (ADMET 2)

Sankhe K, Tumati S, Perin J, Rivet L, Vieira D, Rosenberg PB, Herrmann N, Shade D, Lerner AJ, Padala PR, Brawman-Mintzer O, van Dyck CH, Porsteinsson AP, Craft S, Levey AI, Mintzer J, Lanctôt KL.

Int Psychogeriatr. 2025 Mar;37(2):100012. doi: 10.1016/j.inpsyc.2024.100012. Epub 2024 Dec 4.

Development of AL101 (GSK4527226), a progranulin-elevating monoclonal antibody, as a potential treatment for Alzheimer's disease

Budda B, Mitra A, Park L, Long H, Kurnellas M, Bien-Ly N, Estacio W, Burgess B, Chao G, Schwabe T, Paul R, Kenkare-Mitra S, Rosenthal A.

Alzheimers Res Ther. 2025 Jul 25;17(1):174. doi: 10.1186/s13195-025-01817-4.

Microstructural Hippocampal Alterations in Alzheimer's Disease: A Systematic Review and Meta-Analysis of Diffusion Kurtosis Imaging

Ahmadzadeh AM, Ghaderi S, Mohammadi S, Jashirenezhad N, Fatehi F.

Brain Behav. 2025 Sep;15(9):e70919. doi: 10.1002/brb3.70919.

The Role of c-Abl in Alzheimer's Disease: Guilty or not Guilty?

Li W, Wang X, Liu J, Chen Y.

Cell Mol Neurobiol. 2025 Dec 12;46(1):13. doi: 10.1007/s10571-025-01650-1.

Comparative efficacy and safety of antidiabetic agents in Alzheimer's disease: A network meta-analysis of randomized controlled trials

Cai Z, Zhong J, Zhu G, Zhang J.

J Prev Alzheimers Dis. 2025 May;12(5):100111. doi: 10.1016/j.tjpad.2025.100111. Epub 2025 Feb 28.

Evaluating computational and experimental approaches in early-stage Alzheimer's drug discovery: a systematic review

Azmal M, Paul JK, Shohan MNH, Haque ANMSNB, Mrinmoy M, Talukder OF, Ghosh A.

J Comput Aided Mol Des. 2025 Jun 6;39(1):27. doi: 10.1007/s10822-025-00610-7.

Do exercise interventions improve functional mobility and balance in Alzheimer's patients? A systematic review

Adderley J, Ciccarelli S, Ferraro FV.

J Sports Med Phys Fitness. 2025 Sep;65(9):1235-1244. doi: 10.23736/S0022-4707.25.16503-1. Epub 2025 Jul 15.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias